Parents refile lawsuit over IV rampage deaths
The parents of slain UC Santa Barbara students refiled a lawsuit against Isla Vista apartment property managers alleging they were legally obligated to do more to prevent the shooting that left six dead on May 23, 2014. A federal court dismissed the suit, which previously included the Santa Barbara County Sheriff’s Department as well Read More →
Environmentalists sue regulators for not releasing info on tri-county oil pipelines
Environmental groups have filed lawsuits against federal regulators for allegedly refusing to release information regarding oil pipelines in the Tri-Counties. The Environmental Defense Center and Santa Barbara Channelkeepers sent a Freedom of Information Act request to the Pipeline and Hazardous Materials Safety Administration on May 22. PHMSA has yet to fulfill the FOIA requests, Read More →
CPUC approves Frontier takeover of Verizon subscribers
The California Public Utilities Commission approved on Dec. 4 Frontier Communications’ application to buy all Internet, TV and landline phone subscribers in California from Verizon Communications. Norwalk, Conn.-based Frontier agreed in February to pay Verizon $10.5 billion for all Internet, TV and phone subscribers in California, Texas and Florida. The Federal Communications Commission approved the Read More →
Novartis biosimilar works as well as Amgen’s Neulasta
Swiss pharmaceutical Novartis announced Monday that a copycat version of Amgen’s Neulasta works just as well to prevent a condition that can lead to infection in women with breast cancer. Neulasta stimulates white blood cell production in the body, which helps the body fight cancer. Novartis’ new drug is part of a new class of Read More →
Amgen seeks European OK of biosimilar drug, partners with Merck on studies
Amgen announced two developments Dec. 4 that should help the Thousand Oaks-based biotech giant compete. Amgen said it is seeking approval from the European Medicines Agency for ABP 501, a biosimilar drug similar to Humira. Amgen also announced a partnership with New Jersey-based pharmaceutical Merck to partner in a non-Hodgkins lymphoma study using drugs from Read More →
